Aug 31 (Reuters) - Creso Pharma Ltd (CPH) :
- TO PURSUE NASDAQ & ASX DUAL LISTING FOLLOWING MUTUAL TERMINATION OF PROPOSED MERGER WITH RED LIGHT HOLLAND CORP
- BOARD BELIEVES PURSUING A DUAL NASDAQ LISTING WILL PROVIDE BEST VEHICLE TO PURSUE NORTH AMERICAN FOCUSED GROWTH OPPORTUNITIES
- TARGETING A NASDAQ LISTING DURING H1 CY2022
News: CPH Creso Pharma Says To Pursue Nasdaq & ASX Dual Listing
Add to My Watchlist
What is My Watchlist?